617 related articles for article (PubMed ID: 25701119)
1. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
2. Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer.
Zheng L; Li X; Meng X; Chou J; Hu J; Zhang F; Zhang Z; Xing Y; Liu Y; Xi T
Mol Cell Endocrinol; 2016 May; 427():133-42. PubMed ID: 26980484
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.
Yu W; Chai H; Li Y; Zhao H; Xie X; Zheng H; Wang C; Wang X; Yang G; Cai X; Falck JR; Yang J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):73-83. PubMed ID: 22841774
[TBL] [Abstract][Full Text] [Related]
4. Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer.
Zheng L; Li X; Gu Y; Ma Y; Xi T
Biochem Biophys Res Commun; 2014 Oct; 453(3):545-51. PubMed ID: 25281903
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.
Zheng L; Guo Q; Xiang C; Liu S; Jiang Y; Gao L; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Wang Y; Li X; Xi T
J Hematol Oncol; 2019 Mar; 12(1):23. PubMed ID: 30832689
[TBL] [Abstract][Full Text] [Related]
6. CYP4Z1 3'UTR represses migration of human breast cancer cells.
Wang B; Zheng L; Chou J; Li C; Zhang Y; Meng X; Xi T
Biochem Biophys Res Commun; 2016 Sep; 478(2):900-7. PubMed ID: 27520371
[TBL] [Abstract][Full Text] [Related]
7. The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.
Li C; Zheng L; Xin Y; Tan Z; Zhang Y; Meng X; Wang Z; Xi T
FEBS Lett; 2017 Apr; 591(7):991-1000. PubMed ID: 28236635
[TBL] [Abstract][Full Text] [Related]
8. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.
Wu Q; Yan H; Tao SQ; Wang XN; Mou L; Chen P; Cheng XW; Wu WY; Wu ZS
Oncotarget; 2017 Mar; 8(10):16784-16800. PubMed ID: 28186968
[TBL] [Abstract][Full Text] [Related]
9. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
[TBL] [Abstract][Full Text] [Related]
11. Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity.
Yang W; Yee AJ
Biochim Biophys Acta; 2014 Jul; 1843(7):1373-85. PubMed ID: 24594381
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.
Rieger MA; Ebner R; Bell DR; Kiessling A; Rohayem J; Schmitz M; Temme A; Rieber EP; Weigle B
Cancer Res; 2004 Apr; 64(7):2357-64. PubMed ID: 15059886
[TBL] [Abstract][Full Text] [Related]
13. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
[TBL] [Abstract][Full Text] [Related]
14. IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma.
Gao S; Cheng C; Chen H; Li M; Liu K; Wang G
J Mol Histol; 2016 Apr; 47(2):135-43. PubMed ID: 26759259
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart.
Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Li Y; Li Y; Ye Y
Basic Res Cardiol; 2013 May; 108(3):352. PubMed ID: 23636253
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 3'UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity.
Yang J; Li T; Gao C; Lv X; Liu K; Song H; Xing Y; Xi T
FEBS Lett; 2014 Aug; 588(17):3218-24. PubMed ID: 25017439
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling.
Zhang LF; Zhang JG; Zhou H; Dai TT; Guo FB; Xu SY; Chen Y
Kaohsiung J Med Sci; 2020 Apr; 36(4):250-256. PubMed ID: 31688991
[TBL] [Abstract][Full Text] [Related]
19. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
20. Regulation of AGR2 expression via 3'UTR shortening.
Matoulkova E; Sommerova L; Pastorek M; Vojtesek B; Hrstka R
Exp Cell Res; 2017 Jul; 356(1):40-47. PubMed ID: 28408318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
